DAA2126 |
chromosome 4 open reading frame 34 decreases with age |
Molecular |
ovary |
Human |
SMIM14 |
35.9% Decrease Gene Expression Level |
|
DAA263 |
claudin 8 |
Molecular |
kidney |
Human |
CLDN8 |
17.0% Decrease Gene Expression Level |
|
DAA281 |
coiled-coil domain containing 3 |
Molecular |
kidney |
Human |
CCDC3 |
19.0% Increase Gene Expression Level |
|
DAA275 |
complement component 1, q subcomponent, C chain |
Molecular |
kidney |
Human |
C1QC |
27.0% Increase Gene Expression Level |
|
DAA288 |
complement component 1, r subcomponent |
Molecular |
kidney |
Human |
C1R |
21.0% Increase Gene Expression Level |
|
DAA265 |
complement component 1, s subcomponent |
Molecular |
kidney |
Human |
C1S |
24.0% Increase Gene Expression Level |
|
DAA287 |
creatine kinase, brain |
Molecular |
kidney |
Human |
CKB |
10.0% Decrease Gene Expression Level |
|
DAA273 |
cytoplasmic FMR1 interacting protein 2 |
Molecular |
kidney |
Human |
CYFIP2 |
11.0% Decrease Gene Expression Level |
|
DAA1062 |
Creatinine clearance declines |
Physiological |
kidney |
Human |
— |
— |
|
DAA2063 |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) decreases with age |
Molecular |
ovary |
Human |
CDKN1C |
69.3% Decrease Gene Expression Level |
|
DAA924 |
Decline in ovarian estrogen production |
Physiological |
ovary |
Human |
— |
— |
|
DAA881 |
Dietary protein required to induce renal sclerotic lesions decreases |
Physiological |
renal vasculature |
Human |
— |
— |
|
DAA272 |
dedicator of cytokinesis 11 |
Molecular |
kidney |
Human |
DOCK11 |
24.0% Increase Gene Expression Level |
|
DAA256 |
defensin, beta 1 |
Molecular |
kidney |
Human |
DEFB1 |
8.0% Decrease Gene Expression Level |
|
DAA2066 |
E1A binding protein p300 decreases with age |
Molecular |
ovary |
Human |
EP300 |
69.2% Decrease Gene Expression Level |
|
DAA2064 |
echinoderm microtubule associated protein like 1 decreases with age |
Molecular |
ovary |
Human |
EML1 |
87.8% Decrease Gene Expression Level |
|
DAA258 |
EF-hand domain family, member D1 |
Molecular |
kidney |
Human |
EFHD1 |
9.0% Decrease Gene Expression Level |
|
DAA2108 |
elongation protein 3 homolog (S. cerevisiae) decreases with age |
Molecular |
ovary |
Human |
ELP3 |
54.1% Decrease Gene Expression Level |
|
DAA2065 |
empty spiracles homeobox 1 increases with age |
Molecular |
ovary |
Human |
EMX1 |
80.0% Increase Gene Expression Level |
|
DAA271 |
epidermal growth factor (beta-urogastrone) |
Molecular |
kidney |
Human |
EGF |
25.0% Decrease Gene Expression Level |
|
DAA2067 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) decreases with age |
Molecular |
ovary |
Human |
EPB41 |
42.2% Decrease Gene Expression Level |
|
DAA626 |
Essential (primary) hypertension and hypertensive renal disease |
Pathological |
heart, kidney |
Human |
— |
SeriesMorbidity |
|
DAA2134 |
family with sequence similarity 33, member A; similar to Spindle and kinetochore-associated protein 2 decreases with age |
Molecular |
ovary |
Human |
SKA2P1 |
36.7% Decrease Gene Expression Level |
|
DAA2123 |
F-box and leucine-rich repeat protein 16 decreases with age |
Molecular |
ovary |
Human |
FBXL16 |
51.7% Decrease Gene Expression Level |
|
DAA905 |
Ability to secrete acid load decreases |
Physiological |
kidney |
Human |
— |
— |
|